newsfilter
← Latest News
Business Wire·

Darwin Global Urges Acceleron Shareholders Not to Tender Their Shares to Merck

Believes proposed $180/share offer price is too low and that Acceleron's share price as a standalone company will exceed offer price by at least 2-2.5x Darwin Global Management Limited ("Darwin Global"), a long-term investor in the biotechnology and